Abstract
The discovery of RNA interference (RNAi) has transformed molecular biology and offers enormous therapeutic potential. Currently, there are a few approaches to deliver RNAi into cells including the use of a small interfering RNA (siRNA) or a plasmid to express short hairpin RNA (shRNA) or microRNA. Each of these approaches has its advantages and drawbacks. To fully realise the potential of RNAi in clinic, hurdles including specificity, stability and interferon activation of the small RNA need to be overcome. In order to develop RNAi as pharmaceutics for a range of diseases, strategies to deliver the small RNA in specific cell types need to be further developed and refined. In this chapter, the different classes of small RNA, current strategies to overcome therapeutic hurdles and different methods to deliver RNAi are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Al-Dosari MS, Gao X (2009) Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 11:671–681
Allen LA, Aderem A (1996) Mechanisms of phagocytosis. Curr Opin Immunol 8:36–40
Allerson CR, Sioufi N, Jarres R et al (2005) Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 48:901–904
Balicki D, Putnam CD, Scaria PV et al (2002) Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc Natl Acad Sci USA 99:7467–7471
Banan M, Puri N (2004) The ins and outs of RNAi in mammalian cells. Curr Pharm Biotechnol 5:441–450
Bartlett DW, Davis ME (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res 34:322–333
Belting M, Sandgren S, Wittrup A (2005) Nuclear delivery of macromolecules: barriers and carriers. Adv Drug Deliv Rev 57:505–527
Bennett MJ, Aberle AM, Balasubramaniam RP et al (1997) Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity. J Med Chem 40:4069–4078
Berezikov E, Chung WJ, Willis J et al (2007) Mammalian mirtron genes. Mol Cell 28:328–336
Bernstein E, Caudy AA, Hammond SM et al (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363–366
Bielinska AU, Chen C, Johnson J et al (1999) DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug Chem 10:843–850
Birmingham A, Anderson EM, Reynolds A et al (2006) 3′UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3:199–204
Brodsky FM, Chen CY, Knuehl C et al (2001) Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell Dev Biol 17:517–568
Brooks H, Lebleu B, Vives E (2005) Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57:559–577
Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243–247
Cardoso AL, Simoes S, de Almeida LP et al (2008) Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. J Control Release 132:113–123
Cavazzana-Calvo M, Thrasher A, Mavilio F (2004) The future of gene therapy. Nature 427:779–781
Cerutti H, Casas-Mollano JA (2006) On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet 50:81–99
Check E (2003) Harmful potential of viral vectors fuels doubts over gene therapy. Nature 423:573–574
Chen CC, Sun CP, Ma HI et al (2009) Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol Ther 17:352–359
Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–44
Couzin J (2002) Breakthrough of the year. Small RNAs make big splash. Science 298:2296–2297
Dams ET, Laverman P, Oyen WJ et al (2000) Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 292:1071–1079
Dash PR, Read ML, Barrett LB et al (1999) Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 6:643–650
Dileo J, Miller TE Jr, Chesnoy S et al (2003) Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 14:79–87
Donsante A, Miller DG, Li Y et al (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477
Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007–an update. J Gene Med 9:833–842
El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94:1–14
El-Sayed A, Khalil IA, Kogure K et al (2008) Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 283:23450–23461
Emery DW, Yannaki E, Tubb J et al (2000) A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci USA 97:9150–9155
Erbacher P, Roche AC, Monsigny M et al (1996) Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp Cell Res 225:186–194
Eulalio A, Behm-Ansmant I, Schweizer D et al (2007) P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 27:3970–3981
Farhood H, Serbina N, Huang L (1995) The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1235:289–295
Felgner PL, Ringold GM (1989) Cationic liposome-mediated transfection. Nature 337:387–388
Felgner PL, Gadek TR, Holm M et al (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413–7417
Ferber D (2001) Gene therapy. Safer and virus-free? Science 294:1638–1642
Ferrari A, Pellegrini V, Arcangeli C et al (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther 8:284–294
Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Gao X, Huang L (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 179:280–285
Gautam A, Densmore CL, Xu B et al (2000) Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther 2:63–70
Ge Q, Filip L, Bai A et al (2004) Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci USA 101:8676–8681
Giering JC, Grimm D, Storm TA et al (2008) Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther 16:1630–1636
Giladi H, Ketzinel-Gilad M, Rivkin L et al (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769–776
Godbey WT, Wu KK, Mikos AG (1999) Poly(ethylenimine) and its role in gene delivery. J Control Release 60:149–160
Goldstein DA, Tinland B, Gilbertson LA et al (2005) Human safety and genetically modified plants: a review of antibiotic resistance markers and future transformation selection technologies. J Appl Microbiol 99:7–23
Golzio M, Mazzolini L, Ledoux A et al (2007) In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther 14:752–759
Gong Q, Huntsman C, Ma D (2008) Clathrin-independent internalization and recycling. J Cell Mol Med 12:126–144
Goula D, Remy JS, Erbacher P et al (1998) Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 5:712–717
Goverdhana S, Puntel M, Xiong W et al (2005) Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther 12:189–211
Grayson AC, Doody AM, Putnam D (2006) Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res 23:1868–1876
Green NK, Morrison J, Hale S et al (2008) Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. J Gene Med 10:280–289
Gregory RI, Chendrimada TP, Cooch N et al (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123:631–640
Gregory RI, Chendrimada TP, Shiekhattar R (2006) MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol Biol 342:33–47
Grimm D, Streetz KL, Jopling CL et al (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537–541
Gupta B, Levchenko TS, Torchilin VP (2005) Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 57:637–651
Hagerman PJ (1997) Flexibility of RNA. Annu Rev Biophys Biomol Struct 26:139–156
Hall AH, Wan J, Shaughnessy EE et al (2004) RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res 32:5991–6000
Harris J, Werling D, Hope JC et al (2002) Caveolae and caveolin in immune cells: distribution and functions. Trends Immunol 23:158–164
Hart SL, Collins L, Gustafsson K et al (1997) Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains. Gene Ther 4:1225–1230
Hart SL, Arancibia-Carcamo CV, Wolfert MA et al (1998) Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 9:575–585
Heil F, Ahmad-Nejad P, Hemmi H et al (2003) The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 33:2987–2997
Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
Hornung V, Guenthner-Biller M, Bourquin C et al (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11:263–270
Howard KA, Rahbek UL, Liu X et al (2006) RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 14:476–484
Hoyer J, Neundorf I (2012) Peptide vectors for the nonviral delivery of nucleic acids. Acc Chem Res 45:1048–1056
Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056–2060
Jackson AL, Burchard J, Leake D et al (2006) Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12:1197–1205
Jagannath A, Wood MJ (2009) Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2. Mol Biol Cell 20:521–529
Jakymiw A, Lian S, Eystathioy T et al (2005) Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 7:1267–1274
Jans DA, Hubner S (1996) Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol Rev 76:651–685
Jenkins RG, McAnulty RJ, Hart SL et al (2003) Pulmonary gene therapy. Realistic hope for the future, or false dawn in the promised land? Monaldi Arch Chest Dis 59:17–24
Jing Q, Huang S, Guth S et al (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623–634
John M, Constien R, Akinc A et al (2007) Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449:745–747
Judge AD, Sood V, Shaw JR et al (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23:457–462
Judge AD, Bola G, Lee AC et al (2006) Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 13:494–505
Kaneda Y, Iwai K, Uchida T (1989) Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243:375–378
Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 115:216–225
Kay MA, Liu D, Hoogerbrugge PM (1997) Gene therapy. Proc Natl Acad Sci USA 94:12744–12746
Khalil IA, Futaki S, Niwa M et al (2004) Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 11:636–644
Khalil IA, Kogure K, Akita H et al (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 58:32–45
Kichler A, Leborgne C, Coeytaux E et al (2001) Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med 3:135–144
Kim HH, Choi HS, Yang JM et al (2007) Characterization of gene delivery in vitro and in vivo by the arginine peptide system. Int J Pharm 335:70–78
Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126–139
Kircheis R, Schuller S, Brunner S et al (1999) Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1:111–120
Klein C, Bock CT, Wedemeyer H et al (2003) Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125:9–18
Kobayashi N, Nishikawa M, Hirata K et al (2004) Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 6:584–592
Koide H, Asai T, Hatanaka K et al (2010) T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int J Pharm 392:218–223
Kopatz I, Remy JS, Behr JP (2004) A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med 6:769–776
Koping-Hoggard M, Tubulekas I, Guan H et al (2001) Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8:1108–1121
Kreppel F, Kochanek S (2008) Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther 16:16–29
Kukowska-Latallo JF, Chen C, Eichman J et al (1999) Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro. Biochem Biophys Res Commun 264:253–261
Kumar P, Wu H, McBride JL et al (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39–43
Kwoh DY, Coffin CC, Lollo CP et al (1999) Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta 1444:171–190
Kwok A, Hart SL (2011) Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 7:210–219
Landen CN Jr, Chavez-Reyes A, Bucana C et al (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65:6910–6918
Larson SD, Jackson LN, Chen LA et al (2007) Effectiveness of siRNA uptake in target tissues by various delivery methods. Surgery 142:262–269
Lee RJ, Huang L (1996) Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 271:8481–8487
Lee KY, Kwon IC, Kim YH et al (1998) Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 51:213–220
Lee J, Chuang TH, Redecke V et al (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 100:6646–6651
Leng Q, Scaria P, Lu P et al (2008) Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts. Cancer Gene Ther 15:485–495
Leung RK, Whittaker PA (2005) RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 107:222–239
Li S, Huang L (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7:31–34
Li CX, Parker A, Menocal E et al (2006) Delivery of RNA interference. Cell Cycle 5:2103–2109
Li SD, Chono S, Huang L (2008) Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol Ther 16:942–946
Lian S, Jakymiw A, Eystathioy T et al (2006) GW bodies, microRNAs and the cell cycle. Cell Cycle 5:242–245
Love KT, Mahon KP, Levins CG et al (2010) Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 107:1864–1869
Lundberg M, Wikstrom S, Johansson M (2003) Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 8:143–150
Ma JB, Yuan YR, Meister G et al (2005a) Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature 434:666–670
Ma Z, Li J, He F et al (2005b) Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 330:755–759
Marshall E (2000) Improving gene therapy’s tool kit. Science 288:953
Matsui H, Johnson LG, Randell SH et al (1997) Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 272:1117–1126
Matveev S, Li X, Everson W et al (2001) The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Adv Drug Deliv Rev 49:237–250
Maxfield FR, McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5:121–132
McBride JL, Boudreau RL, Harper SQ et al (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105:5868–5873
McLachlan G, Davidson DJ, Stevenson BJ et al (1995) Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther 2:614–622
Meier O, Greber UF (2003) Adenovirus endocytosis. J Gene Med 5:451–462
Melchior F, Gerace L (1995) Mechanisms of nuclear protein import. Curr Opin Cell Biol 7:310–318
Meyer M, Wagner E (2006) Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer. Hum Gene Ther 17:1062–1076
Minakuchi Y, Takeshita F, Kosaka N et al (2004) Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 32:e109
Monahan PE, Jooss K, Sands MS (2002) Safety of adeno-associated virus gene therapy vectors: a current evaluation. Expert Opin Drug Saf 1:79–91
Morille M, Passirani C, Vonarbourg A et al (2008) Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29:3477–3496
Morrissey DV, Lockridge JA, Shaw L et al (2005) Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23:1002–1007
Nakase I, Niwa M, Takeuchi T et al (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10:1011–1022
Nelson DL, Cox MM (2004) Lehninger principles of biochemistry, 4th edn. W. H. Freeman and Co., New York, NY
Newman CM, Bettinger T (2007) Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 14:465–475
Nichols B (2003) Caveosomes and endocytosis of lipid rafts. J Cell Sci 116:4707–4714
Ogris M, Carlisle RC, Bettinger T et al (2001) Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J Biol Chem 276:47550–47555
Okamura K, Hagen JW, Duan H et al (2007) The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130:89–100
Paddison PJ, Caudy AA, Bernstein E et al (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948–958
Park TG, Jeong JH, Kim SW (2006) Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 58:467–486
Parton RG, Joggerst B, Simons K (1994) Regulated internalization of caveolae. J Cell Biol 127:1199–1215
Patil ML, Zhang M, Betigeri S et al (2008) Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug Chem 19:1396–1403
Pelkmans L, Kartenbeck J, Helenius A (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3:473–483
Perales JC, Grossmann GA, Molas M et al (1997) Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J Biol Chem 272:7398–7407
Pillai RS, Bhattacharyya SN, Filipowicz W (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17:118–126
Preall JB, He Z, Gorra JM et al (2006) Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila. Curr Biol 16:530–535
Ramsay E, Hadgraft J, Birchall J et al (2000) Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro. Int J Pharm 210:97–107
Rand TA, Petersen S, Du F et al (2005) Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123:621–629
Read ML, Singh S, Ahmed Z et al (2005) A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res 33:e86
Reynolds A, Leake D, Boese Q et al (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326–330
Richard JP, Melikov K, Vives E et al (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585–590
Robbins M, Judge A, Ambegia E et al (2008) Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. Hum Gene Ther 19:991–999
Ruby JG, Jan CH, Bartel DP (2007) Intronic microRNA precursors that bypass Drosha processing. Nature 448:83–86
Saito M, Mazda O, Takahashi KA et al (2007) Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res 25:1308–1316
Schaffer DV, Lauffenburger DA (1998) Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J Biol Chem 273:28004–28009
Schaffer DV, Fidelman NA, Dan N et al (2000) Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 67:598–606
Schmid SL (1997) Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 66:511–548
Selkirk SM (2004) Gene therapy in clinical medicine. Postgrad Med J 80:560–570
Semple SC, Akinc A, Chen J et al (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28:172–176
Sen GL, Blau HM (2005) Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7:633–636
Simoes S, Slepushkin V, Pires P et al (1999) Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther 6:1798–1807
Singh R, Tian B, Kostarelos K (2008) Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo. FASEB J 22:3389–3402
Sioud M, Sorensen DR (2003) Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 312:1220–1225
Smart EJ, Graf GA, McNiven MA et al (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289–7304
Soutschek J, Akinc A, Bramlage B et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173–178
Sternberg B, Hong K, Zheng W, Papahadjopoulos D (1998) Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta 1375:23–35
Stoll SM, Sclimenti CR, Baba EJ et al (2001) Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice. Mol Ther 4:122–129
Suzuki T, Nishida K, Kakutani K et al (2009) Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA. Eur Spine J 18:263–270
Swanson JA, Watts C (1995) Macropinocytosis. Trends Cell Biol 5:424–428
Tagalakis AD, Grosse SM, Meng QH et al (2011a) Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration. Biomaterials 32:1370–1376
Tagalakis AD, He L, Saraiva L et al (2011b) Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery. Biomaterials 32:6302–6315
Takei K, Haucke V (2001) Clathrin-mediated endocytosis: membrane factors pull the trigger. Trends Cell Biol 11:385–391
Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346–358
Thoren PE, Persson D, Isakson P et al (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Commun 307:100–107
Thornhill SI, Schambach A, Howe SJ et al (2008) Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther 16:590–598
Thrasher AJ, Hacein-Bey-Abina S, Gaspar HB et al (2005) Failure of SCID-X1 gene therapy in older patients. Blood 105:4255–4257
Tomari Y, Matranga C, Haley B et al (2004) A protein sensor for siRNA asymmetry. Science 306:1377–1380
Toub N, Malvy C, Fattal E et al (2006) Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed Pharmacother 60:607–620
Trehin R, Merkle HP (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 58:209–223
Uchida H, Tanaka T, Sasaki K et al (2004) Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 10:162–171
Urban-Klein B, Werth S, Abuharbeid S et al (2005) RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 12:461–466
Valencia-Sanchez MA, Liu J, Hannon GJ et al (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515–524
Verma IM, Somia N (1997) Gene therapy—promises, problems and prospects. Nature 389:239–242
Vermeulen A, Behlen L, Reynolds A et al (2005) The contributions of dsRNA structure to Dicer specificity and efficiency. RNA 11:674–682
Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010–16017
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310–315
Wagner E, Plank C, Zatloukal K et al (1992) Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 89:7934–7938
Wang CY, Huang L (1987) pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA 84:7851–7855
Wasungu L, Hoekstra D (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116:255–264
Weinberg MS, Wood MJ (2009) Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum Mol Genet 18:R27–R39
Wells DJ (2004) Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 11:1363–1369
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8:129–138
Wienhues U, Hosokawa K, Hoveler A et al (1987) A novel method for transfection and expression of reconstituted DNA-protein complexes in eukaryotic cells. DNA 6:81–89
Williams DA, Baum C (2003) Medicine. Gene therapy–new challenges ahead. Science 302:400–401
Wilusz CJ, Wilusz J (2004) Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet 20:491–497
Winkler KE (2004) Killing the messenger. Nat Rev Drug Discov 3:823–824
Winter J, Jung S, Keller S et al (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228–234
Wrobel I, Collins D (1995) Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1235:296–304
Wu GY, Wu CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262:4429–4432
Xia H, Mao Q, Eliason SL et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10:816–820
Xu B, Wiehle S, Roth JA et al (1998) The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther 5:1235–1243
Zamore PD, Tuschl T, Sharp PA et al (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25–33
Zauner W, Kichler A, Schmidt W et al (1997) Glycerol and polylysine synergize in their ability to rupture vesicular membranes: a mechanism for increased transferrin-polylysine-mediated gene transfer. Exp Cell Res 232:137–145
Zeira E, Manevitch A, Khatchatouriants A et al (2003) Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 8:342–350
Zhang G, Gao X, Song YK et al (2004) Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther 11:675–682
Zheng JN, Pei DS, Mao LJ et al (2009) Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther 16:20–32
Zimmermann TS, Lee AC, Akinc A et al (2006) RNAi-mediated gene silencing in non-human primates. Nature 441:111–114
Zuhorn IS, Bakowsky U, Polushkin E et al (2005) Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol Ther 11:801–810
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kwok, A. (2013). The Challenges and Current Advances in Delivering RNAi as Therapeutics. In: Erdmann, V., Barciszewski, J. (eds) DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. RNA Technologies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36853-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-36853-0_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36852-3
Online ISBN: 978-3-642-36853-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)